The management of autoimmunity in patients with cholestatic liver diseases

References

• Addison T, Gull W. On a certain affection of the skin – vitiligoidea-alpha plana, beta tuberosa. Guy’s Hosp Rep 1851;7:265-76
   Google Scholar
• Hirschfield GM, Gershwin ME. The immunobiology and pathophysiology of primary biliary cirrhosis. Annu Rev Pathol 2013;8:303-30
   PubMed Web of Science ®Google Scholar
• Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 1978;379:103-12
   PubMed Web of Science ®Google Scholar
• Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol 2012;56:1181-8
   PubMed Web of Science ®Google Scholar
• Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet 2003;362:53-61
   PubMed Web of Science ®Google Scholar
• Hirschfield GM, Invernizzi P. Progress in the genetics of primary biliary cirrhosis. Semin Liver Dis 2011;31:147-56
   PubMed Web of Science ®Google Scholar
• Pares A, Rodes J. Natural history of primary biliary cirrhosis. Clin Liver Dis 2003;7:779-94
   PubMedGoogle Scholar
• Gershwin ME, Mackay IR, Sturgess A, et al. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987;138:3525-31
   PubMed Web of Science ®Google Scholar
• Bowlus CL, Gershwin ME. The diagnosis of primary biliary cirrhosis. Autoimmun Rev 2014;13:441-4
   PubMed Web of Science ®Google Scholar
• Floreani A, Franceschet I, Cazzagon N, et al. Extrahepatic Autoimmune Conditions Associated with Primary Biliary Cirrhosis. Clin Rev Allergy Immunol 2014
   Web of Science ®Google Scholar
• Chazouilleres O, Wendum D, Serfaty L, et al. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998;28:296-301
   PubMed Web of Science ®Google Scholar
• Shimoda S, Van de Water J, Ansari A, et al. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 1998;102:1831-40
   PubMed Web of Science ®Google Scholar
• Selmi C, Lleo A, Pasini S, et al. Innate immunity and primary biliary cirrhosis. Curr Mol Med 2009;9:45-51
   PubMed Web of Science ®Google Scholar
• Prince M, Chetwynd A, Newman W, et al. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology 2002;123:1044-51
   PubMed Web of Science ®Google Scholar
• Jones DE, Bhala N, Burt J, et al. Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort. Gut 2006;55:536-41
   PubMed Web of Science ®Google Scholar
• Beuers U, Kremer AE, Bolier R, et al. Pruritus in cholestasis: facts and fiction. Hepatology 2014;60:399-407
   PubMed Web of Science ®Google Scholar
• Carbone M, Bufton S, Monaco A, et al. The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study. J Hepatol 2013;59:490-4
   PubMed Web of Science ®Google Scholar
• Crippin JS, Lindor KD, Jorgensen R, et al. Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk? Hepatology 1992;15:858-62
   PubMed Web of Science ®Google Scholar
• Guanabens N, Monegal A, Cerda D, et al. Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis. Hepatology 2013;58:2070-8
   PubMed Web of Science ®Google Scholar
• Levy C, Lindor KD. Management of osteoporosis, fat-soluble vitamin deficiencies, and hyperlipidemia in primary biliary cirrhosis. Clin Liver Dis 2003;7:901-10
   PubMedGoogle Scholar
• Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology 2009;50:291-308
   PubMed Web of Science ®Google Scholar
• Angulo P, Batts KP, Therneau TM, et al. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. Hepatology 1999;29:644-7
   PubMed Web of Science ®Google Scholar
• Poupon RE, Lindor KD, Cauch-Dudek K, et al. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997;113:884-90
   PubMed Web of Science ®Google Scholar
• Lindor KD, Jorgensen RA, Therneau TM, et al. Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis. Mayo Clin Proc 1997;72:1137-40
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the L. EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol 2009;51:237-67
   PubMed Web of Science ®Google Scholar
• Pares A, Caballeria L, Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterology 2006;130:715-20
   PubMed Web of Science ®Google Scholar
• Silveira MG, Lindor KD. Primary sclerosing cholangitis. Can J Gastroenterol 2008;22:689-98
   PubMed Web of Science ®Google Scholar
• Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010;51:660-78
   PubMed Web of Science ®Google Scholar
• Miloh T, Arnon R, Shneider B, et al. A retrospective single-center review of primary sclerosing cholangitis in children. Clin Gastroenterol Hepatol 2009;7:239-45
   PubMed Web of Science ®Google Scholar
• O’Toole A, Alakkari A, Keegan D, et al. Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease. Clin Gastroenterol Hepatol 2012;10:439-41
   PubMed Web of Science ®Google Scholar
• Fausa O, Schrumpf E, Elgjo K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 1991;11:31-9
   PubMed Web of Science ®Google Scholar
• Bungay H, Buchel O, Travis S, Chapman R. Prevalence and determinants of primary sclerosing cholangitis in a cohort of patients with inflammatory bowel disease and normal liver function tests. Dig Dis 2008;1:A107
   Google Scholar
• Feldstein AE, Perrault J, El-Youssif M, et al. Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology 2003;38:210-17
   PubMed Web of Science ®Google Scholar
• Chazouilleres O. Primary sclerosing cholangitis and bile acids. Clin Res Hepatol Gastroenterol 2012;36(Suppl 1):S21-5
   PubMedGoogle Scholar
• Aron JH, Bowlus CL. The immunobiology of primary sclerosing cholangitis. Semin Immunopathol 2009;31:383-97
   PubMed Web of Science ®Google Scholar
• Tabibian JH, O’Hara SP, Lindor KD. Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies. Scand J Gastroenterol 2014;1-8
   Google Scholar
• Tabibian JH, Weeding E, Jorgensen RA, et al. Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study. Aliment Pharmacol Ther 2013;37:604-12
   PubMed Web of Science ®Google Scholar
• Bambha K, Kim WR, Talwalkar J, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003;125:1364-9
   PubMed Web of Science ®Google Scholar
• Bjoro K, Brandsaeter B, Foss A, et al. Liver transplantation in primary sclerosing cholangitis. Semin Liver Dis 2006;26:69-79
   PubMed Web of Science ®Google Scholar
• Bjornsson E, Simren M, Olsson R, et al. Fatigue in patients with primary sclerosing cholangitis. Scand J Gastroenterol 2004;39:961-8
   PubMed Web of Science ®Google Scholar
• Gotthardt DN, Rupp C, Bruhin M, et al. Pruritus is associated with severely impaired quality of life in patients with primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 2014;26:1374-9
   PubMed Web of Science ®Google Scholar
• Razumilava N, Gores GJ, Lindor KD. Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology 2011;54:1842-52
   PubMed Web of Science ®Google Scholar
• Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology 2011;54:173-84
   PubMed Web of Science ®Google Scholar
• Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 2013;145:1215-29
   PubMed Web of Science ®Google Scholar
• Bjornsson E, Olsson R, Bergquist A, et al. The natural history of small-duct primary sclerosing cholangitis. Gastroenterology 2008;134:975-80
   PubMed Web of Science ®Google Scholar
• Olsson R, Boberg KM, de Muckadell OS, et al. High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology 2005;129:1464-72
   PubMed Web of Science ®Google Scholar
• Lindor KD, Kowdley KV, Luketic VA, et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 2009;50:808-14
   PubMed Web of Science ®Google Scholar
• Wunsch E, Trottier J, Milkiewicz M, et al. Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis. Hepatology 2014;60:931-40
   PubMed Web of Science ®Google Scholar
• Bjornsson E, Chari ST, Smyrk TC, et al. Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology 2007;45:1547-54
   PubMed Web of Science ®Google Scholar
• Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012;366:539-51
   PubMed Web of Science ®Google Scholar
• Hart PA, Kamisawa T, Brugge WR, et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013;62:1771-6
   PubMed Web of Science ®Google Scholar
• Webster GJ, Pereira SP, Chapman RW. Autoimmune pancreatitis/IgG4-associated cholangitis and primary sclerosing cholangitis–overlapping or separate diseases? J Hepatol 2009;51:398-402
   PubMed Web of Science ®Google Scholar
• Bjornsson E. Immunoglobulin G4-associated cholangitis. Curr Opin Gastroenterol 2008;24:389-94
   PubMed Web of Science ®Google Scholar
• Mendes FD, Jorgensen R, Keach J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 2006;101:2070-5
   PubMed Web of Science ®Google Scholar
• Takikawa H, Takamori Y, Tanaka A, et al. Analysis of 388 cases of primary sclerosing cholangitis in Japan; Presence of a subgroup without pancreatic involvement in older patients. Hepatol Res 2004;29:153-9
   PubMed Web of Science ®Google Scholar
• Carey EJ. Cholestatic liver disease. Springer; NY: 2014
   Google Scholar
• Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008;134:706-15
   PubMed Web of Science ®Google Scholar
• Joshi D, Webster G. IgG4 Related Sclerosing Cholangitis. Advances in Hepatol 2014;2015:7
   Google Scholar
• Oseini AM, Chaiteerakij R, Shire AM, et al. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology 2011;54:940-8
   PubMed Web of Science ®Google Scholar
• Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010;51:2193-213
   PubMed Web of Science ®Google Scholar
• Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-76
   PubMed Web of Science ®Google Scholar
• Boberg KM, Chapman RW, Hirschfield GM, et al. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011;54:374-85
   PubMed Web of Science ®Google Scholar
• Floreani A, Franceschet I, Cazzagon N. Primary biliary cirrhosis: overlaps with other autoimmune disorders. Semin Liver Dis 2014;34:352-60
   PubMed Web of Science ®Google Scholar
• Silveira MG, Lindor KD. Overlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases. Expert Rev Gastroenterol Hepatol 2007;1:329-40
   PubMedGoogle Scholar
• Silveira MG, Talwalkar JA, Angulo P, et al. Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. Am J Gastroenterol 2007;102:1244-50
   PubMed Web of Science ®Google Scholar
• Floreani A, Rizzotto ER, Ferrara F, et al. Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome. Am J Gastroenterol 2005;100:1516-22
   PubMed Web of Science ®Google Scholar
• Abdalian R, Dhar P, Jhaveri K, et al. Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging. Hepatology 2008;47:949-57
   PubMed Web of Science ®Google Scholar
• Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38
   PubMed Web of Science ®Google Scholar
• Chazouilleres O, Wendum D, Serfaty L, et al. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol 2006;44:400-6
   PubMed Web of Science ®Google Scholar
• Floreani A, Baragiotta A, Guido M. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: a cause of resistance to ursodeoxycholic treatment. Dig Liver Dis 2003;35:128-9
   PubMedGoogle Scholar
• Floreani A, Liberal R, Vergani D, et al. Autoimmune hepatitis: Contrasts and comparisons in children and adults - a comprehensive review. J Autoimmun 2013;46:7-16
   PubMed Web of Science ®Google Scholar
• Gregorio GV, Portmann B, Karani J, et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 2001;33:544-53
   PubMed Web of Science ®Google Scholar
• Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995;40:1561-8
   PubMed Web of Science ®Google Scholar
• Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002;51:1-4
   PubMed Web of Science ®Google Scholar
• Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001;120:682-707
   PubMed Web of Science ®Google Scholar
• Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003;38:982-4
   PubMed Web of Science ®Google Scholar
• Okazaki K, Uchida K, Ohana M, et al. Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 2000;118:573-81
   PubMed Web of Science ®Google Scholar
• Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-8
   PubMed Web of Science ®Google Scholar
• Ota M, Katsuyama Y, Hamano H, et al. Two critical genes (HLA-DRB1 and ABCF1)in the HLA region are associated with the susceptibility to autoimmune pancreatitis. Immunogenetics 2007;59:45-52
   PubMed Web of Science ®Google Scholar
• Umemura T, Ota M, Hamano H, et al. Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients. Gut 2006;55:1367-8
   PubMed Web of Science ®Google Scholar
• Okazaki K, Uchida K, Chiba T. Recent concept of autoimmune-related pancreatitis. J Gastroenterol 2001;36:293-302
   PubMed Web of Science ®Google Scholar
• Nishimori I, Tamakoshi A, Otsuki M, et al. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in. 2002;J Gastroenterol 2007;42(Suppl 18):6-8
   Google Scholar
• Kanno A, Nishimori I, Masamune A, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan. Pancreas 2012;41:835-9
   PubMed Web of Science ®Google Scholar
• Sah RP, Pannala R, Chari ST, et al. Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol 2010;8:91-6
   PubMed Web of Science ®Google Scholar
• Kim KP, Kim M, Lee YJ, et al. [Clinical characteristics of 17 cases of autoimmune chronic pancreatitis]. Korean J Gastroenterol 2004;43:112-19
   PubMedGoogle Scholar
• Pearson RK, Longnecker DS, Chari ST, et al. Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist? Pancreas 2003;27:1-13
   PubMed Web of Science ®Google Scholar
• Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006;4:1010-16; quiz 934
   PubMed Web of Science ®Google Scholar
• Church NI, Pereira SP, Deheragoda MG, et al. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol 2007;102:2417-25
   PubMed Web of Science ®Google Scholar
• Huggett MT, Culver EL, Kumar M, et al. Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol 2014;109:1675-83
   PubMed Web of Science ®Google Scholar
• Li A, Wang Y, Deng Z. Concurrent autoimmune pancreatitis and primary biliary cirrhosis: a rare case report and literature review. BMC Gastroenterol 2014;14:10
   PubMed Web of Science ®Google Scholar
• Ichimura T, Kondo S, Ambo Y, et al. Primary sclerosing cholangitis associated with autoimmune pancreatitis. Hepatogastroenterology 2002;49:1221-4
   PubMed Web of Science ®Google Scholar
• Park SH, Kim D, Ye BD, et al. The characteristics of ulcerative colitis associated with autoimmune pancreatitis. J Clin Gastroenterol 2013;47:520-5
   PubMed Web of Science ®Google Scholar
• Deshpande V, Chicano S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol 2006;30:1537-45
   PubMed Web of Science ®Google Scholar
• Finkelberg DL, Sahani D, Deshpande V, et al. Autoimmune pancreatitis. N Engl J Med 2006;355:2670-6
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Seko S, Azuma K, et al. Autoimmune pancreatitis detected as a mass in the tail of the pancreas. J Gastroenterol Hepatol 2000;15:461-4
   PubMed Web of Science ®Google Scholar
• Zhang L, Notohara K, Levy MJ, et al. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007;20:23-8
   PubMed Web of Science ®Google Scholar
• Deheragoda MG, Church NI, Rodriguez-Justo M, et al. The use of immunoglobulin g4 immunostaining in diagnosing pancreatic and extrapancreatic involvement in autoimmune pancreatitis. Clin Gastroenterol Hepatol 2007;5:1229-34
   PubMed Web of Science ®Google Scholar
• Notohara K, Burgart LJ, Yadav D, et al. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol 2003;27:1119-27
   PubMed Web of Science ®Google Scholar
• Zamboni G, Luttges J, Capelli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004;445:552-63
   PubMed Web of Science ®Google Scholar
• Park DH, Kim MH, Chari ST. Recent advances in autoimmune pancreatitis. Gut 2009;58:1680-9
   PubMed Web of Science ®Google Scholar
• Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 2010;139:140-8; quiz e12-3
   PubMed Web of Science ®Google Scholar
• Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol 2013;108:610-17
   PubMed Web of Science ®Google Scholar
• Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006;41:626-31
   PubMed Web of Science ®Google Scholar
• Kim KP, Kim MH, Kim JC, et al. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol 2006;12:2487-96
   PubMed Web of Science ®Google Scholar
• Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 2008;43:403-8
   PubMed Web of Science ®Google Scholar
• Yang DH, Kim KW, Kim TK, et al. Autoimmune pancreatitis: radiologic findings in 20 patients. Abdom Imaging 2006;31:94-102
   PubMed Web of Science ®Google Scholar
• Okazaki K. Autoimmune-related Pancreatitis. Curr Treat Options Gastroenterol 2001;4:369-75
   PubMedGoogle Scholar
• Loftus EVJr, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 2002;31:1-20
   PubMed Web of Science ®Google Scholar
• Kornbluth A, Sachar DB; Practice Parameters Committee of the American College of G. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010;105:501-23; quiz 524
   PubMed Web of Science ®Google Scholar
• Chandar AK, Singh S, Murad MH, et al. Efficacy and Safety of Natalizumab and Vedolizumab for the Management of Crohn’s Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis 2015
   Web of Science ®Google Scholar
• Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009;361:2066-78
   PubMed Web of Science ®Google Scholar
• Tabibian JH, O’Hara SP, Larusso NF. Primary sclerosing cholangitis: the gut-liver axis. Clin Gastroenterol Hepatol 2012;10:819; author reply 819-20
   PubMed Web of Science ®Google Scholar
• Olsson R, Bjornsson E, Backman L, et al. Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. J Hepatol 1998;28:426-32
   PubMed Web of Science ®Google Scholar
• Lichtman SN, Keku J, Clark RL, et al. Biliary tract disease in rats with experimental small bowel bacterial overgrowth. Hepatology 1991;13:766-72
   PubMed Web of Science ®Google Scholar
• Olsson R, Danielsson A, Jarnerot G, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991;100:1319-23
   PubMed Web of Science ®Google Scholar
• Rasmussen HH, Fallingborg JF, Mortensen PB, et al. Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn’s disease. Scand J Gastroenterol 1997;32:604-10
   PubMed Web of Science ®Google Scholar
• Dave M, Higgins PD, Middha S, et al. The human gut microbiome: current knowledge, challenges, and future directions. Transl Res 2012;160:246-57
   PubMed Web of Science ®Google Scholar
• Anderson CA, Boucher G, Lees CW, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011;43:246-52
   PubMed Web of Science ®Google Scholar
• Ellinghaus D, Folseraas T, Holm K, et al. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology 2013;58:1074-83
   PubMed Web of Science ®Google Scholar
• Janse M, Lamberts LE, Franke L, et al. Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9. Hepatology 2011;53:1977-85
   PubMed Web of Science ®Google Scholar
• Karlsen TH, Franke A, Melum E, et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 2010;138:1102-11
   PubMed Web of Science ®Google Scholar
• Melum E, Franke A, Schramm C, et al. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet 2011;43:17-19
   PubMed Web of Science ®Google Scholar
• Loftus EVJr, Harewood GC, Loftus CG, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005;54:91-6
   PubMed Web of Science ®Google Scholar
• Boonstra K, Weersma RK, van Erpecum KJ, et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 2013;58:2045-55
   PubMed Web of Science ®Google Scholar
• Moutsopoulos HM, Chused TM, Mann DL, et al. Sjogren’s syndrome (Sicca syndrome): current issues. Ann Intern Med 1980;92:212-26
   PubMed Web of Science ®Google Scholar
• Vitali C. Classification criteria for Sjogren’s syndrome. Ann Rheum Dis 2003;62:94-5; author reply 95
   PubMed Web of Science ®Google Scholar
• Tsianos EV, Hoofnagle JH, Fox PC, et al. Sjogren’s syndrome in patients with primary biliary cirrhosis. Hepatology 1990;11:730-4
   PubMed Web of Science ®Google Scholar
• Malladi AS, Sack KE, Shiboski SC, et al. Primary Sjogren’s syndrome as a systemic disease: a study of participants enrolled in an international Sjogren’s syndrome registry. Arthritis Care Res (Hoboken) 2012;64:911-18
   PubMed Web of Science ®Google Scholar
• Moutsopoulos HM, Mann DL, Johnson AH, et al. Genetic differences between primary and secondary sicca syndrome. N Engl J Med 1979;301:761-3
   PubMed Web of Science ®Google Scholar
• Tishler M, Alosachie I, Barka N, et al. Primary Sjogren’s syndrome and primary biliary cirrhosis: differences and similarities in the autoantibody profile. Clin Exp Rheumatol 1995;13:497-500
   PubMed Web of Science ®Google Scholar
• Carpenter GH, Proctor GB, Pankhurst CL, et al. Sialochemical markers of salivary gland involvement with Sjogren’s syndrome secondary to rheumatoid arthritis and primary biliary cirrhosis. J Oral Pathol Med 2000;29:452-9
   PubMed Web of Science ®Google Scholar
• Gupta RC, Dickson ER, McDuffie FC, et al. Immune complexes in primary biliary cirrhosis. Higher prevalence of circulating immune complexes in patients with associated autoimmune features. Am J Med 1982;73:192-8
   PubMed Web of Science ®Google Scholar
• Penner E. Demonstration of immune complexes containing the ribonucleoprotein antigen Ro in primary biliary cirrhosis. Gastroenterology 1986;90:724-7
   PubMed Web of Science ®Google Scholar
• Tsuneyama K, Van de Water J, Nakanuma Y, et al. Human combinatorial autoantibodies and mouse monoclonal antibodies to PDC-E2 produce abnormal apical staining of salivary glands in patients with coexistent primary biliary cirrhosis and Sjogren’s syndrome. Hepatology 1994;20:893-8
   PubMed Web of Science ®Google Scholar
• Tsuneyama K, Van De Water J, Yamazaki K, et al. Primary biliary cirrhosis an epithelitis: evidence of abnormal salivary gland immunohistochemistry. Autoimmunity 1997;26:23-31
   PubMed Web of Science ®Google Scholar
• Bodenheimer HCJr, Schaffner F. State of the art. Primary biliary cirrhosis and the immune system. Am J Gastroenterol 1979;72:285-96
   PubMed Web of Science ®Google Scholar
• Coll J, Rives A, Grino MC, et al. Prevalence of Sjogren’s syndrome in autoimmune diseases. Ann Rheum Dis 1987;46:286-9
   PubMed Web of Science ®Google Scholar
• Culp KS, Fleming CR, Duffy J, et al. Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc 1982;57:365-70
   PubMed Web of Science ®Google Scholar
• Fujikura S, Davis PA, Prindiville T, et al. Sjogren’s syndrome and primary biliary cirrhosis: presence of autoantibodies to purified mitochondrial 2-OXO acid dehydrogenases. J Rheumatol 1990;17:1453-7
   PubMed Web of Science ®Google Scholar
• Lindgren S, Manthorpe R, Eriksson S. Autoimmune liver disease in patients with primary Sjogren’s syndrome. J Hepatol 1994;20:354-8
   PubMed Web of Science ®Google Scholar
• Montano-Loza AJ, Crispin-Acuna JC, Remes-Troche JM, et al. Abnormal hepatic biochemistries and clinical liver disease in patients with primary Sjogren’s syndrome. Ann Hepatol 2007;6:150-5
   PubMed Web of Science ®Google Scholar
• Mang FW, Michieletti P, O’Rourke K, et al. Primary biliary cirrhosis, sicca complex, and dysphagia. Dysphagia 1997;12:167-70
   PubMed Web of Science ®Google Scholar
• Sheikh SH, Shaw-Stiffel TA. The gastrointestinal manifestations of Sjogren’s syndrome. Am J Gastroenterol 1995;90:9-14
   PubMed Web of Science ®Google Scholar
• Pares A, Grande L, Bruix J, et al. Esophageal dysfunction in primary biliary cirrhosis. J Hepatol 1988;7:362-7
   PubMed Web of Science ®Google Scholar
• Biagini MR, Milani S, Fedi P, et al. Duodenal ulcer and Sjogren’s syndrome in patients with primary biliary cirrhosis: a casual association? Am J Gastroenterol 1991;86:1190-3
   PubMed Web of Science ®Google Scholar
• Newton JL, Hollingsworth KG, Taylor R, et al. Cognitive impairment in primary biliary cirrhosis: symptom impact and potential etiology. Hepatology 2008;48:541-9
   PubMed Web of Science ®Google Scholar
• Tarter RE, Hays AL, Carra J, et al. Sjogren’s syndrome. Its contribution to neuropsychiatric syndrome in patients with primary biliary cirrhosis. Dig Dis Sci 1989;34:9-12
   PubMed Web of Science ®Google Scholar
• Anantharaju A, Baluch M, Van Thiel DH. Transverse myelitis occurring in association with primary biliary cirrhosis and Sjogren’s syndrome. Dig Dis Sci 2003;48:830-3
   PubMed Web of Science ®Google Scholar
• Dorner T, Held C, Trebeljahr G, et al. Serologic characteristics in primary biliary cirrhosis associated with sicca syndrome. Scand J Gastroenterol 1994;29:655-60
   PubMed Web of Science ®Google Scholar
• Zukowski TH, Jorgensen RA, Dickson ER, et al. Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy. Am J Gastroenterol 1998;93:958-61
   PubMed Web of Science ®Google Scholar
• Csepregi A, Szodoray P, Zeher M. Do autoantibodies predict autoimmune liver disease in primary Sjogren’s syndrome? Data of 180 patients upon a 5 year follow-up. Scand J Immunol 2002;56:623-9
   PubMed Web of Science ®Google Scholar
• Klachko DM, Johnson ER. The liver and circulating thyroid hormones. J Clin Gastroenterol 1983;5:465-71
   PubMed Web of Science ®Google Scholar
• Robbins J, Cheng SY, Gershengorn MC, et al. Thyroxine transport proteins of plasma. Molecular properties and biosynthesis. Recent Prog Horm Res 1978;34:477-519
   PubMedGoogle Scholar
• Nomura S, Pittman CS, Chambers JBJr, et al. Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis. J Clin Invest 1975;56:643-52
   PubMed Web of Science ®Google Scholar
• Elta GH, Sepersky RA, Goldberg MJ, et al. Increased incidence of hypothyroidism in primary biliary cirrhosis. Dig Dis Sci 1983;28:971-5
   PubMed Web of Science ®Google Scholar
• Silveira MG, Mendes FD, Diehl NN, et al. Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease. Liver Int 2009;29:1094-100
   PubMed Web of Science ®Google Scholar
• Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 1977;7:481-93
   PubMed Web of Science ®Google Scholar
• Crowe JP, Christensen E, Butler J, et al. Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. Gastroenterology 1980;78:1437-41
   PubMed Web of Science ®Google Scholar
• Vallas M, Monier JC, Tourniaire J, et al. [Prevalence of antimitochondrial antibodies in women with Hashimoto’s thyroiditis]. Presse Med 1994;23:1117-20
   PubMed Web of Science ®Google Scholar
• Horita M, Takahashi N, Seike M, et al. A case of primary biliary cirrhosis associated with Hashimoto’s thyroiditis, scleroderma and Sjogren’s syndrome. Intern Med 1992;31:418-21
   PubMed Web of Science ®Google Scholar
• Nakamura T, Higashi S, Tomoda K, et al. Primary biliary cirrhosis (PBC)-CREST overlap syndrome with coexistence of Sjogren’s syndrome and thyroid dysfunction. Clin Rheumatol 2007;26:596-600
   PubMed Web of Science ®Google Scholar
• Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid 2014;24:1670-751
   PubMed Web of Science ®Google Scholar
• Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 2011;17:456-520
   PubMed Web of Science ®Google Scholar
• Van Thiel DH, Udani M, Schade RR, et al. Prognostic value of thyroid hormone levels in patients evaluated for liver transplantation. Hepatology 1985;5:862-6
   PubMed Web of Science ®Google Scholar
• Gupta RC, Seibold JR, Krishnan MR, et al. Precipitating autoantibodies to mitochondrial proteins in progressive systemic sclerosis. Clin Exp Immunol 1984;58:68-76
   PubMed Web of Science ®Google Scholar
• Powell FC, Schroeter AL, Dickson ER. Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases. Q J Med 1987;62:75-82
   PubMedGoogle Scholar
• Chou MJ, Lai MY, Lee SL, et al. Reactivity of anti-mitochondrial antibodies in primary biliary cirrhosis and systemic sclerosis. J Formos Med Assoc 1992;91:1075-80
   PubMedGoogle Scholar
• Chan HL, Lee YS, Hong HS, et al. Anticentromere antibodies (ACA): clinical distribution and disease specificity. Clin Exp Dermatol 1994;19:298-302
   PubMed Web of Science ®Google Scholar
• Akiyama Y, Tanaka M, Takeishi M, et al. Clinical, serological and genetic study in patients with CREST syndrome. Intern Med 2000;39:451-6
   PubMed Web of Science ®Google Scholar
• Akimoto S, Abe M, Ishikawa O, et al. HLA-DRB1 and DQB1 genes in anticentromere antibody positive patients with SSc and primary biliary cirrhosis. Ann Rheum Dis 2001;60:639-40
   PubMed Web of Science ®Google Scholar
• Mayo MJ, Jenkins RN, Combes B, et al. Association of clonally expanded T cells with the syndrome of primary biliary cirrhosis and limited scleroderma. Hepatology 1999;29:1635-42
   PubMed Web of Science ®Google Scholar
• Fukuhara M, Watanabe T, Ueo T, et al. Enhanced cytokine responses to Toll-like and NOD-like receptor ligands in primary biliary cirrhosis-CREST overlap syndrome. Rheumatology (Oxford) 2010;49:1602-4
   PubMed Web of Science ®Google Scholar
• Lambert NC. [Microchimerism in scleroderma: ten years later]. Rev Med Interne 2010;31:523-9
   PubMed Web of Science ®Google Scholar
• Jacobson DL, Gange SJ, Rose NR, et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997;84:223-43
   PubMedGoogle Scholar
• Murray-Lyon IM, Thompson RP, Ansell ID, et al. Scleroderma and primary biliary cirrhosis. Br Med J 1970;3:258-9
   PubMed Web of Science ®Google Scholar
• Clarke AK, Galbraith RM, Hamilton EB, et al. Rheumatic disorders in primary biliary cirrhosis. Ann Rheum Dis 1978;37:42-7
   PubMed Web of Science ®Google Scholar
• Sakauchi F, Mori M, Zeniya M, et al. A cross-sectional study of primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid. J Epidemiol 2005;15:24-8
   PubMed Web of Science ®Google Scholar
• Liberal R, Grant CR, Sakkas L, et al. Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis. Clin Res Hepatol Gastroenterol 2013;37:572-85
   PubMed Web of Science ®Google Scholar
• Marasini B, Gagetta M, Rossi V, et al. Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients. Ann Rheum Dis 2001;60:1046-9
   PubMed Web of Science ®Google Scholar
• Assassi S, Fritzler MJ, Arnett FC, et al. Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol 2009;36:2250-6
   PubMed Web of Science ®Google Scholar
• Rigamonti C, Shand LM, Feudjo M, et al. Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. Gut 2006;55:388-94
   PubMed Web of Science ®Google Scholar
• Bernstein RM, Callender ME, Neuberger JM, et al. Anticentromere antibody in primary biliary cirrhosis. Ann Rheum Dis 1982;41:612-14
   PubMed Web of Science ®Google Scholar
• Akimoto S, Ishikawa O, Takagi H, et al. Immunological features of patients with primary biliary cirrhosis (PBC) overlapping systemic sclerosis: a comparison with patients with PBC alone. J Gastroenterol Hepatol 1998;13:897-901
   PubMed Web of Science ®Google Scholar
• Norman GL, Bialek A, Encabo S, et al. Is prevalence of PBC underestimated in patients with systemic sclerosis? Dig Liver Dis 2009;41:762-4
   PubMedGoogle Scholar
• Cavazzana I, Ceribelli A, Taraborelli M, et al. Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis. J Rheumatol 2011;38:2180-5
   PubMed Web of Science ®Google Scholar
• Miyawaki S, Asanuma H, Nishiyama S, et al. Clinical and serological heterogeneity in patients with anticentromere antibodies. J Rheumatol 2005;32:1488-94
   PubMed Web of Science ®Google Scholar
• Caramaschi P, Biasi D, Manzo T, et al. Anticentromere antibody–clinical associations. A study of 44 patients. Rheumatol Int 1995;14:253-5
   PubMed Web of Science ®Google Scholar
• Reynolds TB, Denison EK, Frankl HD, et al. Primary biliary cirrhosis with scleroderma, Raynaud’s phenomenon and telangiectasia. New syndrome. Am J Med 1971;50:302-12
   PubMed Web of Science ®Google Scholar
• Costa C, Sambataro A, Baldi S, et al. Primary biliary cirrhosis: lung involvement. Liver 1995;15:196-201
   PubMedGoogle Scholar
• Fonollosa V, Simeon CP, Castells L, et al. Morphologic capillary changes and manifestations of connective tissue diseases in patients with primary biliary cirrhosis. Lupus 2001;10:628-31
   PubMed Web of Science ®Google Scholar
• Vazquez-Abad D, Rothfield NF. Autoantibodies in systemic sclerosis. Int Rev Immunol 1995;12:145-57
   PubMedGoogle Scholar
• Akimoto S, Ishikawa O, Muro Y, et al. Clinical and immunological characterization of patients with systemic sclerosis overlapping primary biliary cirrhosis: a comparison with patients with systemic sclerosis alone. J Dermatol 1999;26:18-22
   PubMedGoogle Scholar
• Fraile G, Rodriguez-Garcia JL, Moreno A. Primary sclerosing cholangitis associated with systemic sclerosis. Postgrad Med J 1991;67:189-92
   PubMed Web of Science ®Google Scholar
• Miller MH, Littlejohn GO, Davidson A, et al. The clinical significance of the anticentromere antibody. Br J Rheumatol 1987;26:17-21
   PubMedGoogle Scholar
• Avouac J, Kowal-Bielecka O, Landewe R, et al. European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research. Ann Rheum Dis 2009;68:629-34
   PubMed Web of Science ®Google Scholar
• McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205-19
   PubMed Web of Science ®Google Scholar
• Smyk DS, Bogdanos DP, Mytilinaiou MG, et al. Rheumatoid arthritis and primary biliary cirrhosis: cause, consequence, or coincidence? Arthritis 2012;2012:391567
   PubMedGoogle Scholar
• Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 1973;289:674-8
   PubMed Web of Science ®Google Scholar
• Watt FE, James OF, Jones DE. Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. QJM 2004;97:397-406
   PubMed Web of Science ®Google Scholar
• Inoue K, Hirohara J, Nakano T, et al. Prediction of prognosis of primary biliary cirrhosis in Japan. Liver 1995;15:70-7
   PubMedGoogle Scholar
• Siegel JL, Luthra H, Donlinger J, et al. Association of primary biliary cirrhosis and rheumatoid arthritis. J Clin Rheumatol 2003;9:340-3
   PubMed Web of Science ®Google Scholar
• Lamberts LE, Janse M, Haagsma EB, et al. Immune-mediated diseases in primary sclerosing cholangitis. Dig Liver Dis 2011;43:802-6
   PubMedGoogle Scholar
• Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-81
   PubMed Web of Science ®Google Scholar
• Caramella C, Avouac J, Sogni P, et al. Association between rheumatoid arthritis and primary biliary cirrhosis. Joint Bone Spine 2007;74:279-81
   PubMed Web of Science ®Google Scholar
• Nishimura K, Sugiyama D, Kogata Y, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007;146:797-808
   PubMed Web of Science ®Google Scholar
• Gow PJ, Fleming KA, Chapman RW. Primary sclerosing cholangitis associated with rheumatoid arthritis and HLA DR4: is the association a marker of patients with progressive liver disease? J Hepatol 2001;34:631-5
   PubMed Web of Science ®Google Scholar
• Singh JA, Furst DE, Bharat A, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64:625-39
   PubMed Web of Science ®Google Scholar
• Volta U, Caio G, Tovoli F, et al. Gut-liver axis: an immune link between celiac disease and primary biliary cirrhosis. Expert Rev Gastroenterol Hepatol 2013;7:253-61
   PubMed Web of Science ®Google Scholar
• Mustalahti K, Catassi C, Reunanen A, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med 2010;42:587-95
   PubMed Web of Science ®Google Scholar
• Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000;119:234-42
   PubMed Web of Science ®Google Scholar
• Dickey W, McMillan SA, Callender ME. High prevalence of celiac sprue among patients with primary biliary cirrhosis. J Clin Gastroenterol 1997;25:328-9
   PubMed Web of Science ®Google Scholar
• Floreani A, Betterle C, Baragiotta A, et al. Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy. Dig Liver Dis 2002;34:258-61
   PubMedGoogle Scholar
• Gillett HR, Cauch-Dudek K, Jenny E, et al. Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis. Can J Gastroenterol 2000;14:672-5
   PubMed Web of Science ®Google Scholar
• Kingham JG, Parker DR. The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 1998;42:120-2
   PubMed Web of Science ®Google Scholar
• Volta U, Rodrigo L, Granito A, et al. Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol 2002;97:2609-13
   PubMed Web of Science ®Google Scholar
• Bardella MT, Quatrini M, Zuin M, et al. Screening patients with celiac disease for primary biliary cirrhosis and vice versa. Am J Gastroenterol 1997;92:1524-6
   PubMed Web of Science ®Google Scholar
• Sorensen HT, Thulstrup AM, Blomqvist P, et al. Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. Gut 1999;44:736-8
   PubMed Web of Science ®Google Scholar
• Rubio-Tapia A, Hill ID, Kelly CP, et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013;108:656-76; quiz 677
   PubMed Web of Science ®Google Scholar
• Shizuma T. Coexistence of Systemic Lupu Erythematosus and Primary Biliary Cirrhosis. J Clin Cell Immun 2014;5
   Google Scholar
• Shizuma T, Kuroda H. A case of primary biliary cirrhosis which developed eight years after diagnosis of systemic lupus erythematosus. Intern Med 2011;50:321-4
   PubMed Web of Science ®Google Scholar
• Efe C, Purnak T, Ozaslan E, et al. Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases. Scand J Gastroenterol 2011;46:732-7
   PubMed Web of Science ®Google Scholar
• Chowdhary VR, Crowson CS, Poterucha JJ, et al. Liver involvement in systemic lupus erythematosus: case review of 40 patients. J Rheumatol 2008;35:2159-64
   PubMed Web of Science ®Google Scholar
• Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009;361:496-509
   PubMed Web of Science ®Google Scholar
• Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007;370:263-71
   PubMed Web of Science ®Google Scholar
• Ohira H, Rai T, Takiguchi J, et al. Six cases of primary biliary cirrhosis complicated by psoriasis. Hepatol Res 2004;30:111-15
   PubMed Web of Science ®Google Scholar
• Efe C, Wahlin S, Ozaslan E, et al. Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. Eur J Gastroenterol Hepatol 2012;24:531-4
   PubMed Web of Science ®Google Scholar
• Joly P, Roujeau JC, Benichou J, et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 2002;346:321-7
   PubMed Web of Science ®Google Scholar
• Hamilton DV, McKenzie AW. Bullous pemphigoid and primary biliary cirrhosis. Br J Dermatol 1978;99:447-50
   PubMed Web of Science ®Google Scholar
• Grange JD, Mallet L, Nochy D, et al. [Bullous pemphigoid in primary biliary cirrhosis]. Gastroenterol Clin Biol 1983;7:828
   PubMed Web of Science ®Google Scholar
• Singhal PC, Scharschmidt LA. Membranous nephropathy associated with primary biliary cirrhosis and bullous pemphigoid. Ann Allergy 1985;55:484-5
   PubMedGoogle Scholar
• Jin Y, Birlea SA, Fain PR, et al. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med 2010;362:1686-97
   PubMed Web of Science ®Google Scholar
• Marcet B, Sibaud V, Geniaux M, et al. [Bullous pemphigoid, primary biliary cirrhosis and vitiligo: a multiple autoimmune syndrome?]. Ann Med Interne (Paris) 2002;153:349-50
   PubMedGoogle Scholar
• Nakouti T, Cholongitas E. Is there an association between vitiligo and primary sclerosing cholangitis? Int J Dermatol 2014;53:e14-16
   PubMed Web of Science ®Google Scholar
• McCann P, Pramanik A. Dysphagia and unexpected myasthenia gravis associated with primary biliary cirrhosis, ulcerative colitis and vitiligo. J Am Geriatr Soc 2004;52:1407-8
   PubMed Web of Science ®Google Scholar
• Al-Ajroush N, Al-Khenaizan S. Isolated nail lichen planus with primary sclerosing cholangitis in a child. Saudi Med J 2007;28:1441-2
   PubMed Web of Science ®Google Scholar
• Tong DC, Ferguson MM. Concurrent oral lichen planus and primary sclerosing cholangitis. Br J Dermatol 2002;147:356-8
   PubMed Web of Science ®Google Scholar
• Kahana M, Trau H, Dolev E, et al. Perforating folliculitis in association with primary sclerosing cholangitis. Am J Dermatopathol 1985;7:271-6
   PubMed Web of Science ®Google Scholar
• Mahajan S, Koranne RV, Sardana K, et al. Perforating folliculitis with jaundice in an Indian male: a rare case with sclerosing cholangitis. Br J Dermatol 2004;150:614-16
   PubMed Web of Science ®Google Scholar
• Dalakas MC. Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 1991;325:1487-98
   PubMed Web of Science ®Google Scholar
• Harada N, Dohmen K, Itoh H, et al. Sibling cases of primary biliary cirrhosis associated with polymyositis, vasculitis and Hashimoto’s thyroiditis. Intern Med 1992;31:289-93
   PubMed Web of Science ®Google Scholar
• Epstein O, Burroughs AK, Sherlock S. Polymyositis and acute onset systemic sclerosis in a patient with primary biliary cirrhosis: a clinical syndrome similar to the mixed connective tissue disease. J R Soc Med 1981;74:456-8
   PubMed Web of Science ®Google Scholar
• Honma F, Shio K, Monoe K, et al. Primary biliary cirrhosis complicated by polymyositis and pulmonary hypertension. Intern Med 2008;47:667-9
   PubMed Web of Science ®Google Scholar
• Kurihara Y, Shishido T, Oku K, et al. Polymyositis associated with autoimmune hepatitis, primary biliary cirrhosis, and autoimmune thrombocytopenic purpura. Mod Rheumatol 2011;21:325-9
   PubMed Web of Science ®Google Scholar
• Ahn JH, Kim TH, Peck KR, et al. A case of polymyositis in a patient with primary biliary cirrhosis treated with D-penicillamine. Korean J Intern Med 1993;8:46-50
   PubMedGoogle Scholar
• Wang L, Zhang FC, Chen H, et al. Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study. World J Gastroenterol 2013;19:5131-7
   PubMed Web of Science ®Google Scholar
• Seibold F, Klein R, Jakob F. Polymyositis, alopecia universalis, and primary sclerosing cholangitis in a patient with Crohn’s disease. J Clin Gastroenterol 1996;23:121-4
   PubMed Web of Science ®Google Scholar